Copertina

Preliminary validation of the Virtual Kitchen Challenge as an objective and sensitive measure of everyday function associated with cerebrovascular disease

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sophia L. Holmqvist, Katie Jobson, Dennis Desalme, Stephanie M. Simone, Molly Tassoni, Moira McKniff, Takehiko Yamaguchi, Ingrid Olson, Nadine Martin, Tania Giovannetti
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
di: Angela van der Putten‐Toorenburg, et al.
Pubblicazione: (2026)

The Virtual Kitchen Challenge: Relations between everyday function and cognition in older adults with healthy or impaired cognition
di: Kimberly Halberstadter, et al.
Pubblicazione: (2025)

The role of cerebrovascular reactivity on brain activation during a working memory task in type 2 diabetes
di: Yarden Oliel, et al.
Pubblicazione: (2025)

The Rapid Naming Test: Neuroanatomical validity and clinical utility
di: Kelly J. Atkins, et al.
Pubblicazione: (2025)

Reliability and validity of the Rhode Island Mobile Cognitive Assessment Tool
di: Laura E. Korthauer, et al.
Pubblicazione: (2026)

Acoustic speech features are associated with late‐life depression and apathy symptoms: Preliminary findings
di: Daniel Harlev, et al.
Pubblicazione: (2025)

NODDI in gray matter is a sensitive marker of aging and early AD changes
di: Xi Yu, et al.
Pubblicazione: (2024)

Culturally adapted cognitive assessment tool for Indigenous communities in Brazil: Content, construct, and criterion validity
di: Camila Carlos Bezerra, et al.
Pubblicazione: (2024)

Clinical validation of the Lilly SP‐X P‐tau217 assay: Performance in underrepresented cohorts
di: Michael E. Hodsdon, et al.
Pubblicazione: (2025)

Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
di: Dustin B. Hammers, et al.
Pubblicazione: (2026)

Correction to “Culturally adapted cognitive assessment tool for Indigenous communities in Brazil: Content, construct, and criterion validity”
Pubblicazione: (2025)

Develop and validate a computable phenotype for the identification of Alzheimer's disease patients using electronic health record data
di: Xing He, et al.
Pubblicazione: (2024)

Microstructural alterations in the locus coeruleus‐entorhinal cortex pathway in Alzheimer's disease and frontotemporal dementia
di: Giulia Quattrini, et al.
Pubblicazione: (2024)

Feasibility, validity, and normative data for the remote Uniform Data Set neuropsychological battery at the University of Pennsylvania Alzheimer's Disease Research Center
di: Katherine Hackett, et al.
Pubblicazione: (2024)

Odor identification and progression to dementia: The role of odor characteristics and set size
di: Eva Dickmänken, et al.
Pubblicazione: (2024)

The relative contribution of modifiable and non‐modifiable factors for determining cognition in mid‐life individuals at risk for late‐life Alzheimer's disease
di: Bolin Cao, et al.
Pubblicazione: (2026)

Differential Associations of Executive Functions on a Performance Based Test of Functional Abilities in Older Adults
di: Moira McKniff, et al.
Pubblicazione: (2025)

Impact of COVID‐19 pandemic on mortality rate in memory clinic patients
di: Els D. Bakker, et al.
Pubblicazione: (2024)

Long‐term cost‐effectiveness of a more accurate diagnostic work‐up for dementia
di: Pieter J. van der Veere, et al.
Pubblicazione: (2025)

Association between BrainAGE and Alzheimer's disease biomarkers
di: Yousaf Abughofah, et al.
Pubblicazione: (2025)

Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
di: Binita Rajbanshi, et al.
Pubblicazione: (2025)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
di: Paul C. Donaghy, et al.
Pubblicazione: (2026)

“I wasn't broken”: Addressing stigma associated with dementia while Walking the Talk for Dementia
di: Kate Irving, et al.
Pubblicazione: (2026)

Hospital admissions for dementia in the Brazilian public health system over the last decade
di: Alberto Fernando Oliveira Justo, et al.
Pubblicazione: (2024)

A virtual reality cognitive screening tool based on the six cognitive domains
di: Ngiap Chuan Tan, et al.
Pubblicazione: (2024)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
di: Rachel R. Jin, et al.
Pubblicazione: (2025)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
di: Julius Opwonya, et al.
Pubblicazione: (2024)

White matter hyperintensities mediate a greater proportion of age‐related lower cognitive scores in non‐Hispanic White participants compared to non‐Hispanic Black and Hispanic participants: HABS‐HD
di: Cellas A. Hayes, et al.
Pubblicazione: (2026)

Feasibility of assessing cognitive impairment via distributed camera network and privacy‐preserving edge computing
di: Chaitra Hegde, et al.
Pubblicazione: (2025)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
di: Elyse Couch, et al.
Pubblicazione: (2025)

Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United States
di: Sephira Ryman, et al.
Pubblicazione: (2026)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
di: Xiang‐Sha Yin, et al.
Pubblicazione: (2025)

Clinical performance of scalable automated p‐tau 217 multi‐analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassay
di: David H. Wilson, et al.
Pubblicazione: (2025)

Impact of sleep disruptions on gray matter structural covariance networks across the Alzheimer's disease continuum
di: Xiao Luo, et al.
Pubblicazione: (2025)

Broadening the concept of suffering is a less than adequate strategy for respecting patients in advanced dementia
di: Paul T. Menzel
Pubblicazione: (2024)

Association of RDoC dimensions with post mortem brain transcriptional profiles in Alzheimer's disease
di: Weiqian Jiang, et al.
Pubblicazione: (2025)

Referral patterns and diagnostic outcomes in an outpatient Australian tertiary cognitive neurology service: 2009–2019
di: Antony Sutherland, et al.
Pubblicazione: (2025)

Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
di: Qi Huang, et al.
Pubblicazione: (2025)

Delayed primacy recall performance predicts post mortem Alzheimer's disease pathology from unimpaired ante mortem cognitive baseline
di: Davide Bruno, et al.
Pubblicazione: (2024)

Exploring neuropsychiatric and behavioral symptoms, and social cognitive deficits in the differential diagnosis of behavioral variant of frontotemporal dementia and primary psychiatric disorders: A systematic literature review
di: Femke G. van Dijk, et al.
Pubblicazione: (2026)